In children with cerebral palsy and impaired immune function, rehabilitation containing thymalin improved neurological defects in 54.55% one month after treatment.
In plain wordsIn children with cerebral palsy and impaired immunity, rehabilitation containing thymalin improved neurological problems in 54.55% one month after treatment.
- Peptide
- Thymalin
- Outcome
- DecreaseNeurological defect
- Study
n: not reported in source
- Outcome group
- Exercise and physical function · Nervous system and cognition
Measurements
- Neurological improvement
- 54.55%
- Children with impaired immune function
Source sentences
Improvement in the neurological defect was observed in 54.55% of children with an impaired function of the immunocompetent system one month after the treatment.
2 context sentences(design, population, supporting numbers)
The immunomodulator thymalin was included in the complex of rehabilitative therapy of 22 children with cerebral paralysis expressed in the form of spastic diplegia and with frequent intercurrent infections.
Immunological parameters were measured before and after treatment to determine the efficiency of the therapy.
In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.